Reuters – Analysts of Kantor Fitzgerald, previously led by Trump’s business Secretary of Trump’s Haward Lutnik, has called for the dismissal of the Robert FCKene Jr.
Kennedy, a well-known vaccine suspicion, announced last week’s plans to reshape federal public health institutions that could include the dismissal of thousands of workers.
Cantor analysts Josh Schimer and Eric Schmidt said in a memorandum on Monday that Kennedy “destroys a reliable leadership in health care in the country.
The note comes after reports suggest that the senior head of the Food and Drug Administration, Peter Marx, had to resign, who had the most out of the organizer, because the Trump administration is carrying out a general reform of federal health institutions.
Lunnik, the billionaire who for 40 years, the CEO of Kantor, resigned last month to run the Trump administration and handed over part of the broker to his two sons. Brandon Lunnik has been appointed president and Kylie Lunnik has been appointed vice-president of the CEO.
Kantor Fitzgerald has not immediately responded to Reuters’ request.
Graduates on Monday led to a decline in biotechnology and vaccine stakes. SPDR S&P Biotech ETF dropped by 3.9%.
Kantor analysts have pointed to the decline in shares, but say their memorandum has nothing to do with politics, shares and sales of biological drugs, but with keeping life in danger.
They said the sources learned from the sources that Marx, who was willing to stay in the FDA, had scientifically reviewed the safety of the vaccines and had not launched an anti-scientific agenda that disrupted public health. They say the same is not said about Kennedy.
“The management has shown the ability to correct the path, compromise and make changes in the necessary location,” he said, adding that “the Washington leaders will recognize the benefits and appreciate that the vaccines can and should play in protecting US citizens.
(Report by Puyaan Singh in Bengali; Editing by Shinjini Gangoli)